Literature DB >> 30566190

Genotype-Guided Medical Treatment of an Arteriovenous Malformation in a Child.

Ramrada Lekwuttikarn1,2, Young H Lim3,4,5, Shehla Admani1, Keith A Choate3,4,5, Joyce M C Teng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30566190      PMCID： PMC7186908          DOI： 10.1001/jamadermatol.2018.4653

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  6 in total

1.  Extracranial arteriovenous malformations: natural progression and recurrence after treatment.

Authors:  Allen S Liu; John B Mulliken; David Zurakowski; Steven J Fishman; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2010-04       Impact factor: 4.730

2.  Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation.

Authors:  Javier A Couto; August Y Huang; Dennis J Konczyk; Jeremy A Goss; Steven J Fishman; John B Mulliken; Matthew L Warman; Arin K Greene
Journal:  Am J Hum Genet       Date:  2017-02-09       Impact factor: 11.025

Review 3.  Trametinib.

Authors:  Robert Zeiser
Journal:  Recent Results Cancer Res       Date:  2014

4.  Surgical management of arteriovenous malformation.

Authors:  Anniek Visser; Trevor FitzJohn; Swee T Tan
Journal:  J Plast Reconstr Aesthet Surg       Date:  2011-03       Impact factor: 2.740

5.  Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Authors:  Rikhia Chakraborty; Oliver A Hampton; Xiaoyun Shen; Stephen J Simko; Albert Shih; Harshal Abhyankar; Karen Phaik Har Lim; Kyle R Covington; Lisa Trevino; Ninad Dewal; Donna M Muzny; Harshavardhan Doddapaneni; Jianhong Hu; Linghua Wang; Philip J Lupo; M John Hicks; Diana L Bonilla; Karen C Dwyer; Marie-Luise Berres; Poulikos I Poulikakos; Miriam Merad; Kenneth L McClain; David A Wheeler; Carl E Allen; D Williams Parsons
Journal:  Blood       Date:  2014-09-08       Impact factor: 22.113

6.  Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.

Authors:  Lara Al-Olabi; Satyamaanasa Polubothu; Katherine Dowsett; Katrina A Andrews; Paulina Stadnik; Agnel P Joseph; Rachel Knox; Alan Pittman; Graeme Clark; William Baird; Neil Bulstrode; Mary Glover; Kristiana Gordon; Darren Hargrave; Susan M Huson; Thomas S Jacques; Gregory James; Hannah Kondolf; Loshan Kangesu; Kim M Keppler-Noreuil; Amjad Khan; Marjorie J Lindhurst; Mark Lipson; Sahar Mansour; Justine O'Hara; Caroline Mahon; Anda Mosica; Celia Moss; Aditi Murthy; Juling Ong; Victoria E Parker; Jean-Baptiste Rivière; Julie C Sapp; Neil J Sebire; Rahul Shah; Branavan Sivakumar; Anna Thomas; Alex Virasami; Regula Waelchli; Zhiqiang Zeng; Leslie G Biesecker; Alex Barnacle; Maya Topf; Robert K Semple; E Elizabeth Patton; Veronica A Kinsler
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808
  6 in total
  15 in total

Review 1.  New and Emerging Targeted Therapies for Vascular Malformations.

Authors:  An Van Damme; Emmanuel Seront; Valérie Dekeuleneer; Laurence M Boon; Miikka Vikkula
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

Review 2.  Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.

Authors:  Takahiro Ota; Masaki Komiyama
Journal:  Interv Neuroradiol       Date:  2020-02-05       Impact factor: 1.610

3.  Endothelial MAP2K1 mutations in arteriovenous malformation activate the RAS/MAPK pathway.

Authors:  Patrick J Smits; Dennis J Konczyk; Christopher L Sudduth; Jeremy A Goss; Arin K Greene
Journal:  Biochem Biophys Res Commun       Date:  2020-07-01       Impact factor: 3.575

Review 4.  Molecular and genetic mechanisms in brain arteriovenous malformations: new insights and future perspectives.

Authors:  Sandra Vetiska; Thomas Wälchli; Ivan Radovanovic; Moncef Berhouma
Journal:  Neurosurg Rev       Date:  2022-10-11       Impact factor: 2.800

5.  Fibroblasts from Patients with Melorheostosis Promote Angiogenesis in Healthy Endothelial Cells through Secreted Factors.

Authors:  Amelia C Hurley-Novatny; Jules D Allbritton-King; Smita Jha; Edward W Cowen; Robert A Colbert; Fatemeh Navid; Timothy Bhattacharyya
Journal:  J Invest Dermatol       Date:  2022-02-19       Impact factor: 7.590

6.  Vascular Malformations: Current Progress Toward Drug Therapy.

Authors:  Arin K Greene; Christopher L Sudduth
Journal:  J Craniofac Surg       Date:  2021-05-01       Impact factor: 1.046

7.  Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.

Authors:  Jason E Fish; Carlos Perfecto Flores Suarez; Emilie Boudreau; Alexander M Herman; Manuel Cantu Gutierrez; Dakota Gustafson; Peter V DiStefano; Meng Cui; Zhiqi Chen; Karen Berman De Ruiz; Taylor S Schexnayder; Christopher S Ward; Ivan Radovanovic; Joshua D Wythe
Journal:  Circ Res       Date:  2020-06-17       Impact factor: 17.367

Review 8.  Cell Populations Expressing Stemness-Associated Markers in Vascular Anomalies.

Authors:  Ethan J Kilmister; Lauren Hansen; Paul F Davis; Sean R R Hall; Swee T Tan
Journal:  Front Surg       Date:  2021-02-09

Review 9.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

Review 10.  A Primer on a Comprehensive Genetic Approach to Vascular Anomalies.

Authors:  Alexandra J Borst; Taizo A Nakano; Francine Blei; Denise M Adams; Jessica Duis
Journal:  Front Pediatr       Date:  2020-10-19       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.